Work

High-dose cyclophosphamide–irinotecan–vincristine for primary refractory neuroblastoma

Year: 2010

Type: article

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2010.09.014

Authors: Brian H. Kushner, Kim Kramer, Shakeel Modak, Karima Yataghene, Nai-Kong V. Cheung

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: G4961134886

OpenAlex ID: W2128187346

FWCI: 1.333

Cites: 39

Cited by: 20

Related to: 10